Amiodarone and optic neuropathy: The heart of the matter

被引：29

作者：

Murphy, MA

Murphy, JF

机构：

[1] Rhode Isl Hosp, Dept Ophthalmol, Brown Med Sch, Providence, RI 02903 USA

[2] Rhode Isl Hosp, Dept Cardiol, Brown Med Sch, Providence, RI 02903 USA

来源：

JOURNAL OF NEURO-OPHTHALMOLOGY | 2005年 / 25卷 / 03期

关键词：

D O I：

10.1097/01.wno.0000177290.09649.38

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Amiodarone is one of the most effective antiarrhythmic drugs currently available. Although a subject of intense controversy, a causal link between amiodarone and optic neuropathy has never been firmly established. Indications for treatment with amiodarone are outlined, and features of the optic neuropathy in patients on amiodarone are compared with those of nonarteritic anterior ischemic optic neuropathy. An approach to patients treated with amiodarone who present with optic neuropathy is outlined, and suggestions for a registry and prospective study of such patients are presented.

引用

页码：232 / 236

页数：5

共 34 条

[1] Visual outcome in eyes with asymptomatic optic disc edema [J].

Almog, Y ;

Goldstein, M .

JOURNAL OF NEURO-OPHTHALMOLOGY, 2003, 23 (03) :204-207

[2]

BECK RW, 1984, OPHTHALMOLOGY, V91, P1334

[3] A randomized study of the prevention of sudden death in patients with coronary artery disease [J].

Buxton, AE ;

Lee, KL ;

Fisher, JD ;

Josephson, ME ;

Prystowsky, EN ;

Hafley, G .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (25) :1882-1890

[4]

Castells David D, 2002, Optometry, V73, P113

[5] Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials [J].

Connolly, SJ ;

Hallstrom, AP ;

Cappato, R ;

Schron, EB ;

Kuck, KH ;

Zipes, DP ;

Greene, HL ;

Boczor, S ;

Domanski, M ;

Follmann, D ;

Gent, M ;

Roberts, RS .

EUROPEAN HEART JOURNAL, 2000, 21 (24) :2071-2078

[6] Amiodarone and optic neuropathy [J].

Domingues, MF ;

Barros, H ;

Falcao-Reis, FM .

ACTA OPHTHALMOLOGICA SCANDINAVICA, 2004, 82 (03) :277-282

[7]

DORO S, 1985, ARCH OPHTHALMOL-CHIC, V103, P1143

[8] MORTALITY AND MORBIDITY IN PATIENTS RECEIVING ENCAINIDE, FLECAINIDE, OR PLACEBO - THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL [J].

ECHT, DS ;

LIEBSON, PR ;

MITCHELL, LB ;

PETERS, RW ;

OBIASMANNO, D ;

BARKER, AH ;

ARENSBERG, D ;

BAKER, A ;

FRIEDMAN, L ;

GREENE, HL ;

HUTHER, ML ;

RICHARDSON, DW .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) :781-788

[9] OPTIC NEUROPATHY AND AMIODARONE THERAPY [J].

FEINER, LA ;

YOUNGE, BR ;

KAZMIER, FJ ;

STRICKER, BHC ;

FRAUNFELDER, FT .

MAYO CLINIC PROCEEDINGS, 1987, 62 (08) :702-717

[10] ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation:: Executive summary -: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation) [J].

Fuster, V ;

Rydén, LE ;

Asinger, RW ;

Cannom, DS ;

Crijns, HJ ;

Frye, RL ;

Halperin, JL ;

Kay, GN ;

Klein, WW ;

Lévy, S ;

McNamara, RL ;

Prystowsky, EN ;

Wann, LS ;

Wyse, DG ;

Gibbons, RJ ;

Antman, EM ;

Alpert, JS ;

Faxon, DP ;

Fuster, V ;

Gregoratos, G ;

Hiratzka, LF ;

Jacobs, AK ;

Russell, RO ;

Smith, SC ;

Klein, WW ;

Alonso-Garcia, A ;

Blomström-Lundqvist, C ;

De Backer, G ;

Flather, M ;

Hradec, J ;

Oto, A ;

Parkhomenko, A ;

Silber, S ;

Torbicki, A .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (04) :1231-1265

← 1 2 3 4 →